50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations
Antibodies · 04.12.2024 · 13 (4) · 99
DOI: 10.3390/antib13040099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibodies, online erschienen am 04.12.2024. Verfasst von Zirui Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ohio State University.
Abstract (Originalsprache)
Background
The complementarity-determining region (CDR) of antibodies represents the most diverse region both in terms of sequence and structural characteristics, playing the most critical role in antibody recognition and binding for immune responses. Over the past decades, several numbering schemes have been introduced to define CDRs based on sequence. However, the existence of diverse numbering schemes has led to potential confusion, and a comprehensive evaluation of these schemes is lacking.
Methods
We employ statistical analyses to quantify the diversity of CDRs compared to the framework regions.
Results
Comparative analyses across different numbering schemes demonstrate notable variations in CDR definitions. The Kabat and AbM numbering schemes tend to incorporate more conserved residues into their CDR definitions, whereas CDRs defined by the Chothia and IMGT numbering schemes display greater diversity, sometimes missing certain loop residues. Notably, we identify a critical residue, L29, within the kappa light chain CDR1, which appears to act as a pivotal structural point within the loop. In contrast, most numbering schemes designate the topological equivalent point in the lambda light chain as L30, suggesting the need for further refinement in the current numbering schemes.
Conclusions
These findings shed light on regional sequence and structural conservation within antibody sequence databases while also highlighting discrepancies stemming from different numbering schemes. These insights yield valuable guidelines for the precise delineation of antibody CDRs and the strategic design of antibody repertoires, with practical implications in developing innovative antibody-based therapeutics and diagnostics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA.
- Chemistry Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Zirui Zhu, Katherine S Olson, Thomas J Magliery
Förderung
- The Ohio State University
Zitieren
APA
Zhu, Z., Olson, K. S., & Magliery, T. J. (2024). 50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations. Antibodies, 13(4), 99. https://doi.org/10.3390/antib13040099
Vancouver
Zhu Z, Olson KS, Magliery TJ. 50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations. Antibodies. 2024;13(4):99. doi:10.3390/antib13040099
BibTeX
@article{Zhu2024,
author = {Zhu, Zirui and Olson, Katherine S and Magliery, Thomas J},
title = {50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations},
journal = {Antibodies},
year = {2024},
volume = {13},
number = {4},
pages = {99},
doi = {10.3390/antib13040099}
}
EUVIMED